Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (18709)	4/6/1998 4:34:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

Just like the PHEn-fen research--which turned out to be mostly one big scare and to which he will never hear any apologizies-the info coming out about tomixifen(sp?) will need to be duplicated and screened before we really know the full benefits/risks to the drug in healthy women. BTW, were the healthy women taking the drug have a family history of BC, or was not a factor in the study? BTW pt2 volume was very light today and I do believe the whole biotech sector was in the dumpster today.